Status:
RECRUITING
Dexmedetomidine Wound Infiltration in Cesarean Section
Lead Sponsor:
Attikon Hospital
Conditions:
Postoperative Pain
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall ...
Detailed Description
Parturients undergoing scheduled cesarean section under combined spinal-epidural anesthesia will be included in the study. Women will be randomly allocated according to the type of the solution used f...
Eligibility Criteria
Inclusion
- pregnancy \>37 weeks, ASA I-II, BMI\<35
Exclusion
- patient refusal, epilepsy, GERD, morbid obesity, drug allergy, ASA class \>2, presence of atrioventricular block, severe systemic disease, multiple gestation, high risk pregnancy, contraindications to epidural technique, a history of severe systemic disease, recreational drug or alcohol use
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 20 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03382938
Start Date
August 23 2019
End Date
November 20 2026
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paraskevi K Matsota
Athens, Other, Greece, 13231